Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EPS (Basic): 2020-2024

Historic EPS (Basic) for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to -$0.44.

  • Burning Rock Biotech's EPS (Basic) fell 91.61% to $0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.23, marking a year-over-year decrease of 106.68%. This contributed to the annual value of -$0.44 for FY2024, which is 50.24% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's EPS (Basic) is -$0.44, which was up 50.24% from -$0.89 recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's EPS (Basic) ranged from a high of -$0.44 in FY2024 and a low of -$1.35 during FY2022.
  • For the 3-year period, Burning Rock Biotech's EPS (Basic) averaged around -$0.90, with its median value being -$0.89 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 95.56% in 2021, then spiked by 50.24% in 2024.
  • Over the past 5 years, Burning Rock Biotech's EPS (Basic) (Yearly) stood at -$0.61 in 2020, then crashed by 95.56% to -$1.20 in 2021, then fell by 12.78% to -$1.35 in 2022, then soared by 33.82% to -$0.89 in 2023, then skyrocketed by 50.24% to -$0.44 in 2024.